The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

NIH-Sponsored Trial of Lassa Vaccine Opens - Viral Hemorrhagic Disease Can be Fatal & Causes Permanent Hearing Loss ...

A renowned virologist and former vice-chancellor of Redeemer’s University, Prof. Oyewale Tomori, has warned that Lassa fever ...

An NIH-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants.

UK health officials are on high alert after a traveler from Nigeria tested positive for Lassa fever Learn about the virus its ...

New research this month shows that the experimental antiviral obeldesivir prevented up to 100% of deaths in monkeys infected ...

Rarely if ever does a newspaper headline include the words “crisis averted,” yet, that is what investments in development ...

The timing is dire: Congo is experiencing the deadliest mpox outbreak in history, with cases exploding in a dozen other ...

Many viral diseases in the country ... viral hemorrhagic fevers (VHF), meaning they cause excessive sickness and blood loss. Recognised examples of such diseases include Ebola, Lassa fever ...

The outbreak began in January, with 419 cases recorded so far, and comes after another mystery illness killed 143 in December ...

Lassa Fever International Conference (LIC), scheduled for September 22–26 this year in Côte d'Ivoire, will focus on outbreak ...